Cost Effectiveness of Drug-Eluting Resorbable Scaffold Versus Angioplasty for Infrapopliteal Artery Disease From the LIFE-BTK Trial
Presenter:
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Grant Support/Research Contract - Shockwave Medical; TriReme Medical; Surmodics; Abbott; Boston Scientific Corporation; Concept Medical
- Advisory Board - Abbott Vascular; Boston Scientific Corporation; Medtronic; BD; Cordis Corporation, a Johnson & Johnson company
- Consultant Fee/Honoraria/Speaker’s Bureau - Abiomed; Terumo Medical Corporation; Inari Medical; Penumbra; Shockwave Medical
- Equity/Stock(s)/Options - Encompass Vascular; Advanced Nanotherapies